Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism

Sanah Essayagh; Jean-Marie Xuereb; Anne-Dominique Terrisse; Lise Tellier-Cirioni; Bernard Pipy; Pierre Sié

doi:10.1160/TH07-02-0082

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 98(04): 831-837
DOI: 10.1160/TH07-02-0082

Endothelium and Vascular Development

Schattauer GmbH

Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism

Authors

Sanah Essayagh

¹Laboratoire de Recherche sur la Thrombose, INSERM U858, Université Paul Sabatier, Toulouse, France
Jean-Marie Xuereb

¹Laboratoire de Recherche sur la Thrombose, INSERM U858, Université Paul Sabatier, Toulouse, France
Anne-Dominique Terrisse

¹Laboratoire de Recherche sur la Thrombose, INSERM U858, Université Paul Sabatier, Toulouse, France
Lise Tellier-Cirioni

¹Laboratoire de Recherche sur la Thrombose, INSERM U858, Université Paul Sabatier, Toulouse, France
Bernard Pipy

²EA 2405, Macrophages, Médiateurs de l’inflammation et interactions cellulaires, Université Paul Sabatier, Toulouse, France
Pierre Sié

¹Laboratoire de Recherche sur la Thrombose, INSERM U858, Université Paul Sabatier, Toulouse, France

Abstract

Summary

Circulating microparticles derived from different types of blood cells have been reported to impair endothelial function and to induce pro-inflammatory and prothrombotic endothelial phenotypes. Although the number of monocyte-derived microparticles (M-MPs) is elevated in the blood of patients with various inflammatory conditions, their interaction with endothelial cells has been poorly investigated so far. In this study, we produced microparticles in vitro from apoptotic human monocytes and examined the effects of their interaction with cultured human umbilical vascular endothelial cells (HUVECs). We found that low concentrations of M-MPs induced the production of reactive oxygen species (ROS), mainly anion superoxide, by the endothelial cells. At sub-toxic concentrations, M-MPs induced a rapid expression of von Willebrand factor at the cell surface, which mediated the transient attachment of non-activated platelets to the endothelium in flow conditions. In parallel, M-MPs up-regulated the expression of functional tissue factor by the endothelial cells. ROS controlled these two major changes and the process involved the phosphorylation of p38 mitogen activated protein kinase. We conclude that M-MPs may contribute to thrombotic events by producing redox signalling in endothelial cells.

Keywords

Endothelial cells - microparticles - monocytes - oxidative stress

Full Text

References

References
1 Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications.. Blood Rev 2007; 21: 157-171.
2 Morel O, Toti F, Hugel B. et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arterioscler Thromb Vasc Biol 2006; 26: 2594-2604.
3 Leroyer AS, Isobe H, Lesèche G. et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques.. J Am Coll Cardiol 2007; 49: 772-777.
4 Brill A, Dashevsky O, Rivo J. et al. Platelet-derived microparticles induce angiogenesis and stimulate postischemic revascularization.. Cardiovasc Res 2005; 67: 30-38.
5 Brodsky SV, Zhang F, Nasjletti A. et al. Endothelium- derived microparticles impair endothelial function in vitro.. Am J Physiol Heart Circ Physiol 2004; 286: H1910-H1915.
6 Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway.. J Biol Chem 1999; 274: 23111-23118.
7 Martin S, Tesse A, Hugel B. et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression.. Circulation 2004; 109: 1653-1659.
8 Essayagh S, Brisset AC, Terrisse AD. et al. Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by beta3-integrin antagonists.. Thromb Haemost 2005; 94: 853-858.
9 Omoto S, Nomura S, Shouzu A. et al. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.. Diabetologia 2002; 45: 550-555.
10 Ogata N, Nomura S, Shouzu A. et al. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy.. Diabetes Res Clin Pract 2006; 73: 241-248.
11 Shet AS, Aras O, Gupta K. et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.. Blood 2003; 102: 2678-2683.
12 Chironi G, Simon A, Hugel B. et al. Circulating leukocyte- derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects.. Arterioscler Thromb Vasc Biol 2006; 26: 2775-2780.
13 Bennett MR. Reactive oxygen species and death: oxidative DNA damage in atherosclerosis.. Circ Res 2001; 88: 648-650.
14 McCarthy NJ, Bennett MR. The regulation of vascular smooth muscle cell apoptosis.. Cardiovasc Res 2000; 45: 747-755.
15 Kolowos W, Gaipl US, Sheriff A. et al. Microparticles shed from different antigen-presenting cells display an individual pattern of surface molecules and a distinct potential of allogenic T-cell activation.. Scand J Immunol 2005; 61: 226-233.
16 del Conde I, Shrimpton CN, Thiagarajan P. et al. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.. Blood 2006; 106: 1604-1611.
17 Brisset AC, Terrisse AD, Dupouy D. et al. Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis.. Thromb Haemost 2003; 90: 511-518.
18 Cadroy Y, Gaspin D, Dupouy D. et al. Heparin reverses the procoagulant properties of stimulated endothelial cells.. Thromb Haemost 1996; 75: 190-195.
19 Ghrib F, Brisset AC, Dupouy D. et al. The expression of tissue factor and tissue factor pathway inhibitor in aortic smooth muscle cells is up-regulated in synthetic compared to contractile phenotype.. Thromb Haemost 2002; 87: 1051-1056.
20 Cai H, Harrison DG. Endothelial dydsfunction in cardiovascular diseases. The role of oxidant stress.. Circ Res 2000; 87: 840-844.
21 Sata M, Suhara T, Walsh K. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy.. Arterioscler Thromb Vasc Biol 2000; 20: 309-316.
22 Jacobi J, Kristal B, Chezar J. et al. Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures.. Free Radic Biol Med 2005; 39: 1238-1248.
23 Janiszewski M, Do Carmo AO, Pedro MA. et al. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway.. Crit Care Med 2004; 32: 818-825.
24 Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling.. Circ Res 2000; 87: 179-183.
25 Vischer UM, Jornot L, Wollheim CB. et al. Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells.. Blood 1995; 85: 3164-3172.
26 Bombeli T, Schwartz BR, Harlan JM. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets.. Blood 1999; 93: 3831-3838.
27 Wu G, Essex DW, Meloni FJ. et al. Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex.. Blood 1997; 90: 2660-2669.
28 Tan L, Kowalska MA, Romo GM. et al. Identification and characterization of endothelial glycoprotein Ib using viper venom proteins modulating cell adhesion.. Blood 1999; 93: 2605-2616.
29 Wu SQ, Aird WC. Thrombin, TNF-alpha, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells.. Am J Physiol Heart Circ Physiol 2005; 289: H873-885.
30 Vega-Ostertag M, Casper K, Swerlick R. et al. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies.. Arthritis Rheum 2005; 52: 1545-1554.
31 Szotowski B, Antoniak S. Goldin-Lang, et al. Antixoidative treatment inhibits the release of thrombogenic tissue factor from irradiation-and cytokin-induced endothelial cells.. Cardiovasc Res 2007; 73: 806-812.
32 Simoncini S, Sapet C, Camoin-Jau L. et al. Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome.. Int Immunol 2005; 17: 489-500.